{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:01:07Z","timestamp":1795096867757,"version":"4.10.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK1739"],"award-info":[{"award-number":["GRK1739"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK1739 \/TP8"],"award-info":[{"award-number":["GRK1739 \/TP8"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Radiotherapy is an important modality in lung cancer treatment. Despite advances in treatment planning and dose delivery, patient benefit is still limited by in-field relapse and metastatic recurrence. Simultaneous application of cisplatinum-based chemotherapy leads to moderately improved outcomes, thus providing proof-of-concept for radiosensitization strategies in lung cancer. In an unbiased functional genetic screen for radiosensitization targets in lung cancer, we identified syntaxin 18, a protein involved in retrograde vesicular transport between the Golgi apparatus and endoplasmic reticulum, as mediator of radioresistance. Downregulation of endogenous syntaxin 18 specifically reduced clonogenic survival of radioresistant and radiosensitive lung cancer cells following X-radiation. Gene expression programs regulating DNA repair, mitotic checkpoints and mitosis were altered in isogenic cells with reduced syntaxin 18 expression. Functionally, this translated into impaired DNA damage-induced cell cycle checkpoints leading to cell death by mitotic catastrophe. Interestingly, downregulation of syntaxin 18 in lung cancer cells also impaired expression of markers of epithelial-mesenchymal-transition, and reduced migration and invasion capacity. These findings suggest that syntaxin 18 is a key player regulating genes responsible for controlling the growth of the primary tumor as well as metastases upon radiotherapy of lung cancer. They provide a promising lead for biologically rational radiosensitization strategies impacting on radiation-induced cell death as well as metastasis.<\/jats:p>","DOI":"10.1038\/s41419-022-04978-4","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:03:08Z","timestamp":1654513388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Clotilde","family":"Thumser-Henner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9695-8771","authenticated-orcid":false,"given":"Sebastian","family":"Oeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Kalmbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Kindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7670-7529","authenticated-orcid":false,"given":"Alexander","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2166-3394","authenticated-orcid":false,"given":"Martin","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"4978_CR1","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Auperin","year":"2010","unstructured":"Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28:2181\u201390.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"4978_CR2","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","volume":"383","author":"YL Wu","year":"2020","unstructured":"Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, et al. Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med. 2020;383:1711\u201323.","journal-title":"N Engl J Med."},{"key":"4978_CR3","first-page":"242","volume":"3","author":"H Uramoto","year":"2014","unstructured":"Uramoto H, Tanaka F. Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res. 2014;3:242\u20139.","journal-title":"Transl Lung Cancer Res"},{"key":"4978_CR4","doi-asserted-by":"publisher","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","volume":"4","author":"ST Durant","year":"2018","unstructured":"Durant ST, Zheng L, Wang Y, Chen K, Zhang L, Zhang T, et al. The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv. 2018;4:eaat1719.","journal-title":"Sci Adv"},{"key":"4978_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.canrad.2019.08.008","volume":"23","author":"S Ferreira","year":"2019","unstructured":"Ferreira S, Dutreix M. DNA repair inhibitors to enhance radiotherapy: Progresses and limitations. Cancer Radiother. 2019;23:883\u201390.","journal-title":"Cancer Radiother"},{"key":"4978_CR6","doi-asserted-by":"publisher","first-page":"13713","DOI":"10.1074\/jbc.275.18.13713","volume":"275","author":"K Hatsuzawa","year":"2000","unstructured":"Hatsuzawa K, Hirose H, Tani K, Yamamoto A, Scheller RH, Tagaya M. Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, intermediate compartment, and cis-Golgi vesicle trafficking. J Biol Chem. 2000;275:13713\u201320.","journal-title":"J Biol Chem"},{"key":"4978_CR7","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1038\/sj.emboj.7600333","volume":"23","author":"K Nakajima","year":"2004","unstructured":"Nakajima K, Hirose H, Taniguchi M, Kurashina H, Arasaki K, Nagahama M, et al. Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J. 2004;23:3216\u201326.","journal-title":"EMBO J"},{"key":"4978_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","volume":"4","author":"RD Timmerman","year":"2018","unstructured":"Timmerman RD, Hu C, Michalski JM, Bradley JC, Galvin J, Johnstone DW, et al. Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer. JAMA Oncol. 2018;4:1287\u20138.","journal-title":"JAMA Oncol"},{"key":"4978_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamaoncol.2018.1251","volume":"4","author":"RD Timmerman","year":"2018","unstructured":"Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, et al. Stereotactic body radiation therapy for operable early-stage lung cancer: Findings from the NRG oncology RTOG 0618 trial. JAMA Oncol. 2018;4:1263\u20136.","journal-title":"JAMA Oncol"},{"key":"4978_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature."},{"key":"4978_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","volume":"9","author":"W Theelen","year":"2021","unstructured":"Theelen W, Chen D, Verma V, Hobbs BP, Peulen HMU, Aerts J, et al. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: A pooled analysis of two randomised trials. Lancet Respir Med. 2021;9:467\u201375.","journal-title":"Lancet Respir Med"},{"key":"4978_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S1470-2045(21)00149-2","volume":"22","author":"NK Altorki","year":"2021","unstructured":"Altorki NK, McGraw TE, Borczuk AC, Saxena A, Port JL, Stiles BM, et al. Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: A single-centre, randomised phase 2 trial. Lancet Oncol. 2021;22:824\u201335.","journal-title":"Lancet Oncol"},{"key":"4978_CR13","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med. 2017;377:1919\u201329.","journal-title":"N Engl J Med"},{"key":"4978_CR14","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1158\/2159-8290.CD-20-0282","volume":"10","author":"MS Binkley","year":"2020","unstructured":"Binkley MS, Jeon YJ, Nesselbush M, Moding EJ, Nabet BY, Almanza D, et al. KEAP1\/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. Cancer Discov. 2020;10:1826\u201341.","journal-title":"Cancer Discov."},{"key":"4978_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2008.07.014","volume":"272","author":"T Bassett","year":"2008","unstructured":"Bassett T, Harpur B, Poon HY, Kuo KH, Lee CH. Effective stimulation of growth in MCF-7 human breast cancer cells by inhibition of syntaxin18 by external guide sequence and ribonuclease P. Cancer Lett. 2008;272:167\u201375.","journal-title":"Cancer Lett"},{"key":"4978_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/15548627.2016.1191730","volume":"12","author":"P Grigaravicius","year":"2016","unstructured":"Grigaravicius P, von Deimling A, Frappart PO. RINT1 functions as a multitasking protein at the crossroads between genomic stability, ER homeostasis, and autophagy. Autophagy. 2016;12:1413\u20135.","journal-title":"Autophagy."},{"key":"4978_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature03097","volume":"432","author":"MB Kastan","year":"2004","unstructured":"Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316\u201323.","journal-title":"Nature."},{"key":"4978_CR18","first-page":"6304","volume":"51","author":"MB Kastan","year":"1991","unstructured":"Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991;51:6304\u201311.","journal-title":"Cancer Res"},{"key":"4978_CR19","doi-asserted-by":"publisher","first-page":"7453","DOI":"10.1038\/sj.onc.1204942","volume":"20","author":"K Koniaras","year":"2001","unstructured":"Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, O\u2019Connell MJ. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene. 2001;20:7453\u201363.","journal-title":"Oncogene."},{"key":"4978_CR20","doi-asserted-by":"publisher","first-page":"71660","DOI":"10.18632\/oncotarget.12311","volume":"7","author":"KA Bridges","year":"2016","unstructured":"Bridges KA, Chen X, Liu H, Rock C, Buchholz TA, Shumway SD, et al. MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Oncotarget. 2016;7:71660\u201372.","journal-title":"Oncotarget."},{"key":"4978_CR21","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","volume":"23","author":"M Castedo","year":"2004","unstructured":"Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene. 2004;23:2825\u201337.","journal-title":"Oncogene."},{"key":"4978_CR22","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4161\/cc.8.8.8203","volume":"8","author":"Y Tao","year":"2009","unstructured":"Tao Y, Leteur C, Yang C, Zhang P, Castedo M, Pierre A, et al. Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints. Cell Cycle. 2009;8:1196\u2013205.","journal-title":"Cell Cycle"},{"key":"4978_CR23","unstructured":"Oeck S. Personal Communication. 2022."},{"key":"4978_CR24","doi-asserted-by":"publisher","first-page":"637565","DOI":"10.3389\/fcell.2021.637565","volume":"9","author":"E Morelli","year":"2021","unstructured":"Morelli E, Speranza EA, Pellegrino E, Beznoussenko GV, Carminati F, Garre M, et al. Activity of the SNARE protein SNAP29 at the endoplasmic reticulum and golgi apparatus. Front Cell Dev Biol. 2021;9:637565.","journal-title":"Front Cell Dev Biol"},{"key":"4978_CR25","doi-asserted-by":"publisher","first-page":"e0119707","DOI":"10.1371\/journal.pone.0119707","volume":"10","author":"F Ulloa","year":"2015","unstructured":"Ulloa F, Gonzalez-Junca A, Meffre D, Barrecheguren PJ, Martinez-Marmol R, Pazos I, et al. Blockade of the SNARE protein syntaxin 1 inhibits glioblastoma tumor growth. PLoS One. 2015;10:e0119707.","journal-title":"PLoS One"},{"key":"4978_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2016.02.061","volume":"472","author":"J Du","year":"2016","unstructured":"Du J, Liu X, Wu Y, Zhu J, Tang Y. Essential role of STX6 in esophageal squamous cell carcinoma growth and migration. Biochem Biophys Res Commun. 2016;472:60\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"4978_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00286-8","volume":"9","author":"S Nothdurft","year":"2020","unstructured":"Nothdurft S, Thumser-Henner C, Breitenbucher F, Okimoto RA, Dorsch M, Opitz CA, et al. Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis. Oncogenesis. 2020;9:102.","journal-title":"Oncogenesis."},{"key":"4978_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"4978_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"4978_CR30","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4978_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1667\/RR14746.1","volume":"188","author":"S Oeck","year":"2017","unstructured":"Oeck S, Malewicz NM, Hurst S, Al-Refae K, Krysztofiak A, Jendrossek V. The Focinator v2-0\u2014Graphical interface, four channels, colocalization analysis and cell phase identification. Radiat Res. 2017;188:114\u201320.","journal-title":"Radiat Res"},{"key":"4978_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04978-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04978-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:58:46Z","timestamp":1669301926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04978-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["4978"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04978-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"5 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"529"}}